Home Immunology & Inflammation ROS chemical - CRM1 inhibitor Piperlongumine For research use only.

Piperlongumine

Synonyms: PPLGM, Piplartine

Piperlongumine (PPLGM, Piplartine), a natural alkaloid from Piper longum L., increases the level of reactive oxygen species (ROS) and selectively kills cancer cells. It is a direct TrxR1 inhibitor with suppressive activity against gastric cancer and a novel inhibitor of CRM1; also an inhibitor of PI3K/Akt/mTOR in human breast cancer cells.

Piperlongumine Chemical Structure

Piperlongumine Chemical Structure

CAS No. 20069-09-4

Purity & Quality Control

Piperlongumine Related Products

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
ZR75-30 Cytotoxicity assay 72 hrs Cytotoxicity against human ZR75-30 cells after 72 hrs by MTT assay, IC50=5.86μM 24937186
HCT116 Cytotoxicity assay 72 hrs Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay, IC50=6.04μM 24937186
MDA-MB-231 Cytotoxicity assay 72 hrs Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay, IC50=8.46μM 24937186
A549 Cytotoxicity assay 72 hrs Cytotoxicity against human A549 cells after 72 hrs by MTT assay, IC50=22.85μM 24937186
WI38 Cytotoxicity assay 72 hrs Cytotoxicity against human WI38 cells after 72 hrs by MTT assay, IC50=26.78μM 24937186
MRC5 Cytotoxicity assay 72 hrs Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay, IC50=35.04μM 24937186
PANC1 Cytotoxicity assay 24 hrs Cytotoxicity against human PANC1 cells assessed as reduction in cell viability after 24 hrs by MTT reduction assay, IC50=3.2μM 25305718
HaCaT Cytotoxicity assay 24 hrs Cytotoxicity against human HaCaT cells assessed as reduction in cell viability after 24 hrs by MTT reduction assay, IC50=16μM 25305718
RAW264.7 Antiinflammatory assay Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production, IC50=3μM 25453809
MA9.3 Cytotoxicity assay 48 hrs Cytotoxicity against human MA9.3 cells after 48 hrs by MTT assay, IC50=2μM 25464887
SK-MEL-2 Antiproliferative assay 72 hrs Antiproliferative activity against human SK-MEL-2 cells after 72 hrs by MTT assay, EC50=4.39μM 25826398
HaCaT Antiproliferative assay 72 hrs Antiproliferative activity against human HaCaT cells after 72 hrs by MTT assay, EC50=4.46μM 25826398
A375 Antiproliferative assay 72 hrs Antiproliferative activity against human A375 cells after 72 hrs by MTT assay, EC50=6.17μM 25826398
HCT116 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, EC50=11.5μM 25826398
A549 Antiproliferative assay 72 hrs Antiproliferative activity against human A549 cells after 72 hrs by MTT assay, EC50=12.2μM 25826398
HFF1 Antiproliferative assay 72 hrs Antiproliferative activity against HFF1 cells after 72 hrs by MTT assay, EC50=13.1μM 25826398
MCF10A Antiproliferative assay 72 hrs Antiproliferative activity against human MCF10A cells after 72 hrs by MTT assay, EC50=18.1μM 25826398
A549 Function assay 3 hrs Induction of ROS production in human A549 cells after 3 hrs by DHE staining-based fluorescence assay 25826398
A549 Function assay 3 hrs Induction of ROS production in human A549 cells after 3 hrs by APF staining-based fluorescence assay 25826398
A549 Function assay 10 uM 4 hrs Reduction in total GSH level in human A549 cells at 10 uM after 4 hrs by luminescence assay 25826398
A549 Function assay 10 uM 4 hrs Reduction in reduced GSH level in human A549 cells at 10 uM after 4 hrs by luminescence assay 25826398
HT1080 Cytotoxicity assay 72 hrs Cytotoxicity against human HT1080 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=3.43μM 26599530
GBM10 Cytotoxicity assay 72 hrs Cytotoxicity against human GBM10 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=3.81μM 26599530
SF188 Cytotoxicity assay 72 hrs Cytotoxicity against human SF188 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=3.9μM 26599530
SKBR3 Cytotoxicity assay 72 hrs Cytotoxicity against human SKBR3 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=4.04μM 26599530
T98G Cytotoxicity assay 72 hrs Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=4.92μM 26599530
HT-29 Cytotoxicity assay 72 hrs Cytotoxicity against human HT-29 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=5.49μM 26599530
MCF7 Cytotoxicity assay 72 hrs Cytotoxicity against human MCF7 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=6.14μM 26599530
A549 Cytotoxicity assay 72 hrs Cytotoxicity against human A549 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=6.54μM 26599530
MV4-11 Antiproliferative assay 72 hrs Antiproliferative activity against human MV4-11 cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.2891μM 27505848
CMK Antiproliferative assay 72 hrs Antiproliferative activity against Ara-C resistant human CMK cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.4218μM 27505848
CMY Antiproliferative assay 72 hrs Antiproliferative activity against human CMY cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.4424μM 27505848
HL60 Antiproliferative assay 72 hrs Antiproliferative activity against human HL60 cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.5292μM 27505848
CMK Antiproliferative assay 72 hrs Antiproliferative activity against human CMK cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.6127μM 27505848
U937 Antiproliferative assay 72 hrs Antiproliferative activity against p53 null human U937 cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.767μM 27505848
MOLM13 Antiproliferative assay 72 hrs Antiproliferative activity against human MOLM13 cells harboring wild type p53/FLT3-ITD mutant after 72 hrs in presence of SAHA by MTT assay, IC50=0.9345μM 27505848
CMS Antiproliferative assay 72 hrs Antiproliferative activity against human CMS cells after 72 hrs in presence of SAHA by MTT assay, IC50=1.037μM 27505848
OCI-AML3 Antiproliferative assay 72 hrs Antiproliferative activity against human OCI-AML3 cells after 72 hrs in presence of SAHA by MTT assay, IC50=1.109μM 27505848
HL60 Antiproliferative assay 72 hrs Antiproliferative activity against Ara-C resistant human HL60 cells after 72 hrs in presence of SAHA by MTT assay, IC50=1.128μM 27505848
MV4-11 Antiproliferative assay 72 hrs Antiproliferative activity against human MV4-11 cells after 72 hrs by MTT assay, IC50=1.439μM 27505848
CMY Antiproliferative assay 72 hrs Antiproliferative activity against human CMY cells after 72 hrs by MTT assay, IC50=1.62μM 27505848
HL60 Antiproliferative assay 72 hrs Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay, IC50=1.778μM 27505848
MOLM13 Antiproliferative assay 72 hrs Antiproliferative activity against human MOLM13 cells harboring wild type p53/FLT3-ITD mutant after 72 hrs by MTT assay, IC50=1.838μM 27505848
OCI-AML3 Antiproliferative assay 72 hrs Antiproliferative activity against human OCI-AML3 cells after 72 hrs by MTT assay, IC50=1.868μM 27505848
CMK Antiproliferative assay 72 hrs Antiproliferative activity against Ara-C resistant human CMK cells after 72 hrs by MTT assay, IC50=1.911μM 27505848
U937 Antiproliferative assay 72 hrs Antiproliferative activity against p53 null human U937 cells after 72 hrs by MTT assay, IC50=2.174μM 27505848
HL60 Antiproliferative assay 72 hrs Antiproliferative activity against Ara-C resistant human HL60 cells after 72 hrs by MTT assay, IC50=2.25μM 27505848
CMK Antiproliferative assay 72 hrs Antiproliferative activity against human CMK cells after 72 hrs by MTT assay, IC50=2.815μM 27505848
CMS Antiproliferative assay 72 hrs Antiproliferative activity against human CMS cells after 72 hrs by MTT assay, IC50=3.097μM 27505848
U937 Apoptosis assay 2 uM 24 hrs Induction of apoptosis in p53 null human U937 cells assessed as caspase 3 cleavage at 2 uM after 24 hrs in presence of SAHA by Western blot analysis 27505848
U937 Apoptosis assay 2 uM 24 hrs Induction of apoptosis in p53 null human U937 cells assessed as PARP-1 cleavage at 2 uM after 24 hrs in presence of SAHA by Western blot analysis 27505848
U937 Cell death assay 1 to 4 uM 24 hrs Induction of cell death in p53 null human U937 cells at 1 to 4 uM after 24 hrs by annexin V-FITC/PI staining based flow cytometry 27505848
U937 Cytotoxicity assay 0.5 to 5 uM 24 hrs Cytotoxicity against p53 null human U937 cells assessed as decrease in cell viability at 0.5 to 5 uM after 24 hrs in presence of SAHA by MTT assay 27505848
U937 Function assay 2 uM 20 hrs Induction of DNA damage in p53 null human U937 cells at 2 uM after 20 hrs in presence of SAHA by SYBR gold staining based alkaline comet assay 27505848
MCF7 Antiproliferative assay 48 hrs Antiproliferative activity in human MCF7 cells assessed as cell viability after 48 hrs by alamarBlue assay, IC50=1.2μM 27689728
Jurkat Antiproliferative assay 48 hrs Antiproliferative activity in human Jurkat cells assessed as cell viability after 48 hrs by alamarBlue assay, IC50=1.4μM 27689728
Jurkat Cytotoxicity assay 24 hrs Cytotoxicity against human Jurkat cells after 24 hrs by MTT assay, IC50=5μM 27689728
MCF7 Cytotoxicity assay 24 hrs Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay, IC50=8μM 27689728
MCF7 Apoptosis assay 10 uM 48 hrs Induction of apoptosis in human MCF7 cells assessed as downregulation of Bcl2 expression at 10 uM after 48 hrs by Western blot method 27689728
MCF7 Apoptosis assay 10 uM 72 hrs Induction of apoptosis in human MCF7 cells assessed as downregulation of Mcl-1 expression at 10 uM after 72 hrs by Western blot method 27689728
MCF7 Function assay 20 uM 16 hrs Disruption of microtubule network in human MCF7 cells at 20 uM after 16 hrs by immunofluorescence analysis 27689728
MCF7 Function assay 10 uM 16 hrs Induction of microtubule depolymerization in human MCF7 cells at 10 uM after 16 hrs by immunofluorescence analysis 27689728
MCF7 Function assay 1 to 20 uM 48 hrs Induction of reactive oxygen species generation in human MCF7 cells assessed as decrease in cell viability at 1 to 20 uM in presence of trolox after 48 hrs by alamarBlue assay 27689728
MCF7 Function assay 5 to 20 uM 4 hrs Induction of tubulin depolymerization in human MCF7 cells at 5 to 20 uM after 4 hrs by Western blot method 27689728
Jurkat Function assay 5 to 20 uM 4 hrs Induction of tubulin depolymerization in human Jurkat cells at 5 to 20 uM after 4 hrs by Western blot method 27689728
A549 Function assay 24 hrs Inhibition of NF-kappaB in human A549 cells after 24 hrs by luciferase reporter gene assay, IC50=1.76μM 27810594
HepG2 Cytotoxicity assay 72 hrs Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50=8.9μM 28159415
HCT116 Cytotoxicity assay 72 hrs Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50=9.2μM 28159415
A549 Cytotoxicity assay 72 hrs Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50=10μM 28159415
MRC5 Cytotoxicity assay 72 hrs Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay, IC50=37μM 28159415
A549 Antiproliferative assay 72 hrs Antiproliferative activity against human A549 cells after 72 hrs by MTT assay, IC50=6.84μM 28434764
Saos2 Antiproliferative assay 72 hrs Antiproliferative activity against human Saos2 cells after 72 hrs by MTT assay, IC50=7.31μM 28434764
HCT116 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=7.34μM 28434764
U2OS Antiproliferative assay 72 hrs Antiproliferative activity against human U2OS cells after 72 hrs by MTT assay, IC50=9.49μM 28434764
MDA-MB-231 Antiproliferative assay 72 hrs Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay, IC50=10.6μM 28434764
SKHEP1 Antiproliferative assay 72 hrs Antiproliferative activity against human SKHEP1 cells after 72 hrs by MTT assay, IC50=13.3μM 28434764
HCT116 Function assay 10 uM 1 hr Induction of reactive oxygen species generation in human HCT116 cells at 10 uM after 1 hr by DCFH-DA dye-based fluorescence microscopic analysis 28434764
HCT116 Cell cycle assay 1 to 5 uM 24 hrs Cell cycle arrest in human HCT116 cells assessed as accumulation at S phase 1 to 5 uM after 24 hrs by propidium iodide staining based flow cytometric method 28434764
HCT116 Cell cycle assay 1 to 5 uM 24 hrs Cell cycle arrest in human HCT116 cells assessed as accumulation at G0/G1 phase at 1 to 5 uM after 24 hrs by propidium iodide staining based flow cytometric method 28434764
HCT116 Cell cycle assay 1 to 5 uM 24 hrs Cell cycle arrest in human HCT116 cells decrease in population at G0/G1 phase at 1 to 5 uM after 24 hrs by propidium iodide staining based flow cytometric method 28434764
HT-29 Antiproliferative assay 72 hrs Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay, IC50=2.65μM 28686911
HCT8 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay, IC50=4.1μM 28686911
HCT116 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=8.13μM 28686911
CCD-841 Cytotoxicity assay 72 hrs Cytotoxicity against human CCD-841 cells assessed as reduction in cell viability after 72 hrs by MTT assay, IC50=44.32μM 28686911
HCT116 Antiproliferative assay 10 uM 72 hrs Antiproliferative activity against human HCT116 cells at 10 uM after 72 hrs by MTT assay 28686911
A549 Antiproliferative assay 10 uM 72 hrs Antiproliferative activity against human A549 cells at 10 uM after 72 hrs by MTT assay 28686911
K562 Antiproliferative assay 10 uM 72 hrs Antiproliferative activity against human K562 cells at 10 uM after 72 hrs by MTT assay 28686911
HT-29 Antiproliferative assay 72 hrs Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay, IC50=2.65μM 29424539
HCT8 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay, IC50=4.1μM 29424539
SW620 Antiproliferative assay 72 hrs Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay, IC50=4.62μM 29424539
K562 Antiproliferative assay 72 hrs Antiproliferative activity against human K562 cells after 72 hrs by MTT assay, IC50=5.05μM 29424539
K562 Antiproliferative assay 72 hrs Antiproliferative activity against human K562 cells after 72 hrs in presence of ligustrazine by MTT assay, IC50=5.09μM 29424539
HCT116 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=8.13μM 29424539
HCT116 Antiproliferative assay 72 hrs Antiproliferative activity against human HCT116 cells after 72 hrs in presence of ligustrazine by MTT assay, IC50=8.17μM 29424539
A549 Antiproliferative assay 72 hrs Antiproliferative activity against human A549 cells after 72 hrs in presence of ligustrazine by MTT assay, IC50=15.22μM 29424539
A549 Antiproliferative assay 72 hrs Antiproliferative activity against human A549 cells after 72 hrs by MTT assay, IC50=15.28μM 29424539
U87MG Antiproliferative assay 72 hrs Antiproliferative activity against human U87MG cells after 72 hrs in presence of ligustrazine by MTT assay, IC50=16.15μM 29424539
U87MG Antiproliferative assay 72 hrs Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay, IC50=17.34μM 29424539
CCD-841 Antiproliferative assay 72 hrs Antiproliferative activity against human CCD-841 cells after 72 hrs by MTT assay, IC50=44.32μM 29424539
HCT116 Antimigratory assay 50 nM 48 hrs Antimigratory activity in human HCT116 cells assessed as inhibition of TGF-beta1-induced cell migration at 50 nM after 48 hrs by trans-well assay 29424539
HCT116 Function assay 10 uM 3 hrs Induction of ROS accumulation in human HCT116 cells at 10 uM after 3 hrs by DCFH-DA staining-based fluorescence microscopic analysis 29424539
HCT116 Antiproliferative assay 8 uM 72 hrs Antiproliferative activity against human HCT116 cells at 8 uM after 72 hrs by MTT assay 29424539
HCT116 Antiinvasive assay 50 nM 48 hrs Antiinvasive activity in human HCT116 cells assessed as inhibition of TGF-beta1-induced cell invasion at 50 nM after 48 hrs by crystal violet staining-based assay 29424539
HCT116 Function assay 50 nM 1 hr Inhibition of IL-1beta-mediated adhesion of human rhodamine 123-labeled HCT116 cells to HUVEC at 50 nM after 1 hr by fluoresence assay 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-induced decrease in expression levels of E-cadherin protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-induced increase in expression levels of vimentin protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-induced increase in expression levels of MMP-9 protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-induced increase in expression levels of snail protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-induced increase in expression levels of twist protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-induced AKT phosphorylation in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-induced GSK-3beta phosphorylation in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-regulated decrease in cytoplasmic beta-catenin in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
HCT116 Function assay 50 nM 48 hrs Inhibition of TGF-beta1-regulated increase in nuclear beta-catenin in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis 29424539
DU145 Function assay 24 hrs Inhibition of STAT3 phosphorylation at Tyr705 residues in human DU145 cells after 24 hrs by Western blot analysis, IC50=7μM 29807795
DU145 Growth inhibition assay 48 hrs Growth inhibition of human DU145 cells after 48 hrs by WST-1 assay, GI50=7.1μM 29807795
LNCAP Growth inhibition assay 48 hrs Growth inhibition of human LNCAP cells after 48 hrs by WST-1 assay, GI50=9.2μM 29807795
WI38 Function assay Senolytic activity against ionizing radiation induced human WI38 senescent cells assessed as reduction in cell viability by propidium iodide staining based flow cytometry, EC50=8μM 29925484
WI38 Function assay Senolytic activity against non-senescent human WI38 cells assessed as reduction in cell viability by propidium iodide staining based flow cytometry, EC50=20.3μM 29925484
WI38 Function assay 5 uM 24 hrs Induction of OXR1 degradation in ionizing radiation induced human WI38 senescent cells at 5 uM after 24 hrs by Western blot analysis 29925484
WI38 Function assay up to 64 uM 1.5 hrs Induction of ROS production in ionizing radiation induced human WI38 senescent cells up to 64 uM after 1.5 hrs by DHR123 dye based flow cytometry 29925484
RAW264.7 Function assay 10 uM 0.5 hrs Inhibition of MAPK/NFkappaB in ICR mouse RAW264.7 cells assessed as reduction in LPS-induced TNFalpha production at 10 uM pretreated for 0.5 hrs followed by LPS challenge and measured after 24 hrs by ELISA relative to control 30780088
RAW264.7 Function assay 10 uM 0.5 hrs Inhibition of MAPK/NFkappaB in ICR mouse RAW264.7 cells assessed as reduction in LPS-induced IL6 production at 10 uM pretreated for 0.5 hrs followed by LPS challenge and measured after 24 hrs by ELISA relative to control 30780088
BHK21 Cytotoxicity assay 48 hrs Cytotoxicity against BHK21 cells assessed as reduction in cell viability after 48 hrs by MTT assay, CC50=40.14μM 31009908
SH-SY5Y Cytotoxicity assay 72 hrs Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay, IC50=5.94μM 31400708
U87 Cytotoxicity assay 72 hrs Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay, IC50=7.18μM 31400708
SH-SY5Y Function assay 15 mins Inhibition of TrxR in human SH-SY5Y cells using DTNB as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by Ellman's method, IC50=45.88μM 31400708
Click to View More Cell Line Experimental Data

Biological Activity

Description Piperlongumine (PPLGM, Piplartine), a natural alkaloid from Piper longum L., increases the level of reactive oxygen species (ROS) and selectively kills cancer cells. It is a direct TrxR1 inhibitor with suppressive activity against gastric cancer and a novel inhibitor of CRM1; also an inhibitor of PI3K/Akt/mTOR in human breast cancer cells.
Targets
reactive oxygen species (ROS) [1] TrxR1 [5] CRM1 [6] PI3K/Akt/mTOR [7]
In vitro
In vitro Piperlongumine is a known ROS inducer which could induce pancreatic cancer cell death in cell culture[1] As a thromboxane A(2) receptor antagonist, Piperlongumine inhibits platelet aggregation. [2] Piperlongumine also promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death. [3]
Cell Research Cell lines MCF-7 and 786-O cells
Concentrations ~10 μM
Incubation Time 48 hours
Method

MCF-7 and 786-O cells are incubated with various PL concentrations for 48h. Cell proliferation is analysed by CellTiter Blue assay. Effective doses (ED) are calculated using XLift, Microsoft Excel add-in.
Experimental Result Images Methods Biomarkers Images PMID
Western blot CDK2 / Cyclin E / Cyclin A Bax / Bcl-2 Survivin / p21 / p27 p-STAT3 / STAT3 / p-JAK2 / JAK2 / c-myc Hexokinase 1 / Hexokinase 2 p-AKT / AKT / p-S6 / S6 27634873
Growth inhibition assay Cell viability 25193861
In Vivo
In vivo Piperlongumine (50 mg/kg i.p.) causes in vivo growth inhibition of tumor cells without leading to major changes in the biochemical, hematological and histopathological parameters. [4]
Animal Research Animal Models Mice transplanted with sarcoma 180 tumors
Dosages ~50 mg/kg
Administration i.p.

Chemical Information & Solubility

Molecular Weight 317.34 Formula

C17H19NO5
CAS No. 20069-09-4 SDF Download Piperlongumine SDF
Smiles COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 63 mg/mL ( (198.52 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 63 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Piperlongumine | Piperlongumine supplier | purchase Piperlongumine | Piperlongumine cost | Piperlongumine manufacturer | order Piperlongumine | Piperlongumine distributor